| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 563.69B | 562.40B | 540.15B | 456.48B | 389.90B | 374.21B |
| Gross Profit | 269.13B | 267.44B | 254.89B | 204.46B | 172.81B | 164.17B |
| EBITDA | 107.54B | 102.61B | 111.51B | 70.59B | 48.73B | 49.65B |
| Net Income | 57.22B | 52.12B | 61.69B | 38.92B | 21.27B | 19.22B |
Balance Sheet | ||||||
| Total Assets | 701.71B | 718.28B | 672.87B | 618.64B | 555.82B | 519.08B |
| Cash, Cash Equivalents and Short-Term Investments | 176.10B | 188.75B | 139.88B | 121.44B | 117.69B | 102.92B |
| Total Debt | 24.13B | 34.05B | 32.88B | 57.07B | 54.05B | 54.65B |
| Total Liabilities | 229.46B | 242.56B | 228.10B | 231.81B | 215.47B | 204.31B |
| Stockholders Equity | 463.50B | 467.86B | 436.64B | 379.63B | 333.59B | 308.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 72.11B | 39.70B | 19.58B | 33.52B | 16.33B |
| Operating Cash Flow | 0.00 | 99.03B | 63.83B | 40.42B | 51.64B | 32.84B |
| Investing Cash Flow | 0.00 | -28.64B | 2.65B | -32.94B | -28.33B | -18.62B |
| Financing Cash Flow | 0.00 | -26.24B | -57.50B | -10.93B | -16.16B | -17.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.67T | 27.48 | 11.96% | 1.21% | 4.63% | 12.32% | |
75 Outperform | ¥370.54B | 28.83 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥328.31B | 25.60 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥594.58B | 38.64 | 5.25% | 2.13% | -2.23% | 130.96% | |
71 Outperform | €354.79B | 15.98 | 14.28% | 2.40% | 8.03% | 23.50% | |
68 Neutral | ¥775.64B | 21.36 | ― | 1.81% | -1.44% | 50.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |